Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

PRVA vs DOCS vs HIMS vs WELL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PRVA
Privia Health Group, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$3.01B
5Y Perf.-45.9%
DOCS
Doximity, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$5.24B
5Y Perf.-55.3%
HIMS
Hims & Hers Health, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$6.63B
5Y Perf.+135.7%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+156.3%

PRVA vs DOCS vs HIMS vs WELL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PRVA logoPRVA
DOCS logoDOCS
HIMS logoHIMS
WELL logoWELL
IndustryMedical - Healthcare Information ServicesMedical - Healthcare Information ServicesMedical - Equipment & ServicesREIT - Healthcare Facilities
Market Cap$3.01B$5.24B$6.63B$149.25B
Revenue (TTM)$2.25B$638M$2.35B$11.63B
Net Income (TTM)$3.08B$239M$128M$1.43B
Gross Margin7.0%89.7%69.7%39.1%
Operating Margin1.6%37.4%4.6%4.4%
Forward P/E68.5x16.8x51.5x78.4x
Total Debt$10M$12M$1.12B$21.38B
Cash & Equiv.$480M$210M$229M$5.03B

PRVA vs DOCS vs HIMS vs WELLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PRVA
DOCS
HIMS
WELL
StockJun 21May 26Return
Privia Health Group… (PRVA)10054.1-45.9%
Doximity, Inc. (DOCS)10044.7-55.3%
Hims & Hers Health,… (HIMS)100235.7+135.7%
Welltower Inc. (WELL)100256.3+156.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: PRVA vs DOCS vs HIMS vs WELL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 3 of 7 categories, making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. Doximity, Inc. is the stronger pick specifically for valuation and capital efficiency and operational efficiency and capital deployment. PRVA and HIMS also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
PRVA
Privia Health Group, Inc.
The Quality Compounder

PRVA is the clearest fit if your priority is quality.

  • 137.2% margin vs HIMS's 5.5%
Best for: quality
DOCS
Doximity, Inc.
The Defensive Pick

DOCS is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 1.03, Low D/E 1.1%, current ratio 6.97x
  • Lower P/E (16.8x vs 78.4x)
  • 20.7% ROA vs PRVA's 0.9%, ROIC 20.0% vs 9.9%
Best for: sleep-well-at-night
HIMS
Hims & Hers Health, Inc.
The Growth Play

HIMS is the clearest fit if your priority is growth exposure.

  • Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
  • 59.0% revenue growth vs DOCS's 20.0%
Best for: growth exposure
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 0.13, yield 1.3%
  • 223.1% 10Y total return vs HIMS's 161.9%
  • Beta 0.13, yield 1.3%, current ratio 5.34x
  • Beta 0.13 vs HIMS's 2.40, lower leverage
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthHIMS logoHIMS59.0% revenue growth vs DOCS's 20.0%
ValueDOCS logoDOCSLower P/E (16.8x vs 78.4x)
Quality / MarginsPRVA logoPRVA137.2% margin vs HIMS's 5.5%
Stability / SafetyWELL logoWELLBeta 0.13 vs HIMS's 2.40, lower leverage
DividendsWELL logoWELL1.3% yield; 2-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)WELL logoWELL+42.7% vs DOCS's -55.4%
Efficiency (ROA)DOCS logoDOCS20.7% ROA vs PRVA's 0.9%, ROIC 20.0% vs 9.9%

PRVA vs DOCS vs HIMS vs WELL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PRVAPrivia Health Group, Inc.
FY 2025
FFS-Patient Care
64.1%$1.4B
Capitated Revenue
14.5%$308M
Shared Savings
11.1%$235M
FFS-Administrative Services
6.5%$137M
Care Management Fee (PMPM)
3.4%$73M
Other Revenue
0.4%$9M
DOCSDoximity, Inc.
FY 2025
Subscription
95.3%$544M
Service, Other
4.7%$27M
HIMSHims & Hers Health, Inc.

Segment breakdown not available.

WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M

PRVA vs DOCS vs HIMS vs WELL — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDOCSLAGGINGHIMS

Income & Cash Flow (Last 12 Months)

DOCS leads this category, winning 3 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 18.2x DOCS's $638M. PRVA is the more profitable business, keeping 137.2% of every revenue dollar as net income compared to HIMS's 5.5%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPRVA logoPRVAPrivia Health Gro…DOCS logoDOCSDoximity, Inc.HIMS logoHIMSHims & Hers Healt…WELL logoWELLWelltower Inc.
RevenueTrailing 12 months$2.2B$638M$2.3B$11.6B
EBITDAEarnings before interest/tax$48M$250M$164M$2.8B
Net IncomeAfter-tax profit$3.1B$239M$128M$1.4B
Free Cash FlowCash after capex-$49.3B$314M$73M$2.5B
Gross MarginGross profit ÷ Revenue+7.0%+89.7%+69.7%+39.1%
Operating MarginEBIT ÷ Revenue+1.6%+37.4%+4.6%+4.4%
Net MarginNet income ÷ Revenue+137.2%+37.5%+5.5%+12.3%
FCF MarginFCF ÷ Revenue-21.9%+49.2%+3.1%+21.9%
Rev. Growth (YoY)Latest quarter vs prior year+25.8%+9.8%+28.4%+40.3%
EPS Growth (YoY)Latest quarter vs prior year-33.3%-16.2%-27.3%+22.5%
DOCS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

DOCS leads this category, winning 3 of 6 comparable metrics.

At 23.5x trailing earnings, DOCS trades at a 85% valuation discount to WELL's 153.3x P/E. On an enterprise value basis, DOCS's 21.1x EV/EBITDA is more attractive than WELL's 66.4x.

MetricPRVA logoPRVAPrivia Health Gro…DOCS logoDOCSDoximity, Inc.HIMS logoHIMSHims & Hers Healt…WELL logoWELLWelltower Inc.
Market CapShares × price$3.0B$5.2B$6.6B$149.2B
Enterprise ValueMkt cap + debt − cash$2.5B$5.0B$7.5B$165.6B
Trailing P/EPrice ÷ TTM EPS133.28x23.45x50.32x153.25x
Forward P/EPrice ÷ next-FY EPS est.68.48x16.83x51.51x78.42x
PEG RatioP/E ÷ EPS growth rate0.30x
EV / EBITDAEnterprise value multiple57.62x21.14x42.68x66.40x
Price / SalesMarket cap ÷ Revenue1.42x9.18x2.82x13.99x
Price / BookPrice ÷ Book value/share3.91x4.84x12.25x3.35x
Price / FCFMarket cap ÷ FCF18.58x19.64x89.61x52.41x
DOCS leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

DOCS leads this category, winning 6 of 8 comparable metrics.

DOCS delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $2 for PRVA. DOCS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), DOCS scores 9/9 vs HIMS's 4/9, reflecting strong financial health.

MetricPRVA logoPRVAPrivia Health Gro…DOCS logoDOCSDoximity, Inc.HIMS logoHIMSHims & Hers Healt…WELL logoWELLWelltower Inc.
ROE (TTM)Return on equity+1.5%+24.4%+23.7%+3.5%
ROA (TTM)Return on assets+0.9%+20.7%+6.0%+2.3%
ROICReturn on invested capital+9.9%+20.0%+10.7%+0.5%
ROCEReturn on capital employed+4.6%+22.3%+10.9%+0.6%
Piotroski ScoreFundamental quality 0–95947
Debt / EquityFinancial leverage0.01x0.01x2.07x0.49x
Net DebtTotal debt minus cash-$470M-$197M$892M$16.3B
Cash & Equiv.Liquid assets$480M$210M$229M$5.0B
Total DebtShort + long-term debt$10M$12M$1.1B$21.4B
Interest CoverageEBIT ÷ Interest expense0.26x
DOCS leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $4,911 for DOCS. Over the past 12 months, WELL leads with a +42.7% total return vs DOCS's -55.4%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs DOCS's -8.8% — a key indicator of consistent wealth creation.

MetricPRVA logoPRVAPrivia Health Gro…DOCS logoDOCSDoximity, Inc.HIMS logoHIMSHims & Hers Healt…WELL logoWELLWelltower Inc.
YTD ReturnYear-to-date+2.3%-39.9%-23.2%+14.3%
1-Year ReturnPast 12 months+2.9%-55.4%-51.0%+42.7%
3-Year ReturnCumulative with dividends-19.8%-24.2%+116.6%+189.5%
5-Year ReturnCumulative with dividends-26.1%-50.9%+137.6%+202.3%
10-Year ReturnCumulative with dividends+4.3%-50.9%+161.9%+223.1%
CAGR (3Y)Annualised 3-year return-7.1%-8.8%+29.4%+42.5%
WELL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

WELL leads this category, winning 2 of 2 comparable metrics.

WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than HIMS's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.0% from its 52-week high vs DOCS's 34.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPRVA logoPRVAPrivia Health Gro…DOCS logoDOCSDoximity, Inc.HIMS logoHIMSHims & Hers Healt…WELL logoWELLWelltower Inc.
Beta (5Y)Sensitivity to S&P 5001.03x1.03x2.40x0.13x
52-Week HighHighest price in past year$26.51$76.51$70.43$219.59
52-Week LowLowest price in past year$18.77$20.55$13.74$142.65
% of 52W HighCurrent price vs 52-week peak+90.5%+34.0%+36.4%+97.0%
RSI (14)Momentum oscillator 0–10055.660.154.560.2
Avg Volume (50D)Average daily shares traded901K2.7M34.9M2.6M
WELL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: PRVA as "Buy", DOCS as "Buy", HIMS as "Hold", WELL as "Buy". Consensus price targets imply 64.4% upside for DOCS (target: $43) vs 6.3% for WELL (target: $227). WELL is the only dividend payer here at 1.30% yield — a key consideration for income-focused portfolios.

MetricPRVA logoPRVAPrivia Health Gro…DOCS logoDOCSDoximity, Inc.HIMS logoHIMSHims & Hers Healt…WELL logoWELLWelltower Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$31.67$42.79$29.67$226.50
# AnalystsCovering analysts22221934
Dividend YieldAnnual dividend ÷ price+1.3%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$2.76
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.3%+1.4%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

DOCS leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WELL leads in 2 (Total Returns, Risk & Volatility).

Best OverallDoximity, Inc. (DOCS)Leads 3 of 6 categories
Loading custom metrics...

PRVA vs DOCS vs HIMS vs WELL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PRVA or DOCS or HIMS or WELL a better buy right now?

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 20. 0% for Doximity, Inc. (DOCS). Doximity, Inc. (DOCS) offers the better valuation at 23. 5x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate Privia Health Group, Inc. (PRVA) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PRVA or DOCS or HIMS or WELL?

On trailing P/E, Doximity, Inc.

(DOCS) is the cheapest at 23. 5x versus Welltower Inc. at 153. 3x. On forward P/E, Doximity, Inc. is actually cheaper at 16. 8x.

03

Which is the better long-term investment — PRVA or DOCS or HIMS or WELL?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -50. 9% for Doximity, Inc. (DOCS). Over 10 years, the gap is even starker: WELL returned +223. 1% versus DOCS's -50. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PRVA or DOCS or HIMS or WELL?

By beta (market sensitivity over 5 years), Welltower Inc.

(WELL) is the lower-risk stock at 0. 13β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 1707% more volatile than WELL relative to the S&P 500. On balance sheet safety, Doximity, Inc. (DOCS) carries a lower debt/equity ratio of 1% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PRVA or DOCS or HIMS or WELL?

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 20. 0% for Doximity, Inc. (DOCS). On earnings-per-share growth, the picture is similar: Privia Health Group, Inc. grew EPS 63. 6% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PRVA or DOCS or HIMS or WELL?

Doximity, Inc.

(DOCS) is the more profitable company, earning 39. 1% net margin versus 1. 1% for Privia Health Group, Inc. — meaning it keeps 39. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOCS leads at 39. 9% versus 1. 6% for PRVA. At the gross margin level — before operating expenses — DOCS leads at 90. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PRVA or DOCS or HIMS or WELL more undervalued right now?

On forward earnings alone, Doximity, Inc.

(DOCS) trades at 16. 8x forward P/E versus 78. 4x for Welltower Inc. — 61. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DOCS: 64. 4% to $42. 79.

08

Which pays a better dividend — PRVA or DOCS or HIMS or WELL?

In this comparison, WELL (1.

3% yield) pays a dividend. PRVA, DOCS, HIMS do not pay a meaningful dividend and should not be held primarily for income.

09

Is PRVA or DOCS or HIMS or WELL better for a retirement portfolio?

For long-horizon retirement investors, Welltower Inc.

(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WELL: +223. 1%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PRVA and DOCS and HIMS and WELL?

These companies operate in different sectors (PRVA (Healthcare) and DOCS (Healthcare) and HIMS (Healthcare) and WELL (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

WELL pays a dividend while PRVA, DOCS, HIMS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

PRVA

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 82%
Run This Screen
Stocks Like

DOCS

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 22%
Run This Screen
Stocks Like

HIMS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PRVA and DOCS and HIMS and WELL on the metrics below

Revenue Growth>
%
(PRVA: 25.8% · DOCS: 9.8%)
Net Margin>
%
(PRVA: 137.2% · DOCS: 37.5%)
P/E Ratio<
x
(PRVA: 133.3x · DOCS: 23.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.